ANDLAUER HEALTHCARE GROUP IN (AND.CA) Stock Fundamental Analysis
TSX:AND - Toronto Stock Exchange - CA0342231077 - Common Stock - Currency: CAD
We assign a fundamental rating of 6 out of 10 to AND. AND was compared to 15 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making AND a very profitable company, without any liquidiy or solvency issues. AND is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year AND was profitable.
In the past year AND had a positive cash flow from operations.
In the past 5 years AND has always been profitable.
In the past 5 years AND always reported a positive cash flow from operatings.
1.2 Ratios
AND has a Return On Assets of 9.83%. This is in the better half of the industry: AND outperforms 80.00% of its industry peers.
Looking at the Return On Equity, with a value of 15.77%, AND belongs to the top of the industry, outperforming 86.67% of the companies in the same industry.
With an excellent Return On Invested Capital value of 11.91%, AND belongs to the best of the industry, outperforming 86.67% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AND is above the industry average of 8.13%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.83% | ||
| ROE | 15.77% | ||
| ROIC | 11.91% |
ROA(3y)9.88%
ROA(5y)11.71%
ROE(3y)15.44%
ROE(5y)22.37%
ROIC(3y)11.97%
ROIC(5y)12.76%
1.3 Margins
AND's Profit Margin of 10.69% is amongst the best of the industry. AND outperforms 86.67% of its industry peers.
In the last couple of years the Profit Margin of AND has remained more or less at the same level.
With an excellent Operating Margin value of 14.36%, AND belongs to the best of the industry, outperforming 86.67% of the companies in the same industry.
In the last couple of years the Operating Margin of AND has remained more or less at the same level.
AND's Gross Margin of 33.63% is on the low side compared to the rest of the industry. AND is outperformed by 60.00% of its industry peers.
In the last couple of years the Gross Margin of AND has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.36% | ||
| PM (TTM) | 10.69% | ||
| GM | 33.63% |
OM growth 3Y-4.81%
OM growth 5Y-1.42%
PM growth 3Y-21.44%
PM growth 5Y-0.72%
GM growth 3Y-14.76%
GM growth 5Y-10.42%
2. Health
2.1 Basic Checks
AND has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for AND has been reduced compared to 1 year ago.
The number of shares outstanding for AND has been increased compared to 5 years ago.
Compared to 1 year ago, AND has a worse debt to assets ratio.
2.2 Solvency
AND has an Altman-Z score of 5.53. This indicates that AND is financially healthy and has little risk of bankruptcy at the moment.
AND's Altman-Z score of 5.53 is amongst the best of the industry. AND outperforms 93.33% of its industry peers.
AND has a debt to FCF ratio of 1.74. This is a very positive value and a sign of high solvency as it would only need 1.74 years to pay back of all of its debts.
AND has a better Debt to FCF ratio (1.74) than 93.33% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that AND is not too dependend on debt financing.
AND has a better Debt to Equity ratio (0.21) than 86.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 1.74 | ||
| Altman-Z | 5.53 |
ROIC/WACC1.57
WACC7.57%
2.3 Liquidity
A Current Ratio of 1.26 indicates that AND should not have too much problems paying its short term obligations.
The Current ratio of AND (1.26) is better than 93.33% of its industry peers.
AND has a Quick Ratio of 1.22. This is a normal value and indicates that AND is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of AND (1.22) is better than 93.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.22 |
3. Growth
3.1 Past
AND shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.26%.
Measured over the past years, AND shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.82% on average per year.
AND shows a small growth in Revenue. In the last year, the Revenue has grown by 1.72%.
Measured over the past years, AND shows a quite strong growth in Revenue. The Revenue has been growing by 17.53% on average per year.
EPS 1Y (TTM)5.26%
EPS 3Y-10.45%
EPS 5Y14.82%
EPS Q2Q%5.71%
Revenue 1Y (TTM)1.72%
Revenue growth 3Y13.91%
Revenue growth 5Y17.53%
Sales Q2Q%3.07%
3.2 Future
Based on estimates for the next years, AND will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.89% on average per year.
The Revenue is expected to grow by 3.67% on average over the next years.
EPS Next Y13.36%
EPS Next 2Y12.5%
EPS Next 3Y8.89%
EPS Next 5YN/A
Revenue Next Year3.95%
Revenue Next 2Y4.23%
Revenue Next 3Y3.67%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 33.33 indicates a quite expensive valuation of AND.
Compared to the rest of the industry, the Price/Earnings ratio of AND indicates a somewhat cheap valuation: AND is cheaper than 66.67% of the companies listed in the same industry.
AND's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.30.
A Price/Forward Earnings ratio of 26.67 indicates a quite expensive valuation of AND.
Based on the Price/Forward Earnings ratio, AND is valued a bit cheaper than 73.33% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AND to the average of the S&P500 Index (21.76), we can say AND is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.33 | ||
| Fwd PE | 26.67 |
4.2 Price Multiples
73.33% of the companies in the same industry are more expensive than AND, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, AND is valued a bit cheaper than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.92 | ||
| EV/EBITDA | 13.43 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AND does not grow enough to justify the current Price/Earnings ratio.
AND has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.5
PEG (5Y)2.25
EPS Next 2Y12.5%
EPS Next 3Y8.89%
5. Dividend
5.1 Amount
With a yearly dividend of 0.91%, AND is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.22, AND pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.37, AND's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.91% |
5.2 History
The dividend of AND decreases each year by -34.89%.
AND has been paying a dividend for over 5 years, so it has already some track record.
AND has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-34.89%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
AND pays out 24.69% of its income as dividend. This is a sustainable payout ratio.
DP24.69%
EPS Next 2Y12.5%
EPS Next 3Y8.89%
TSX:AND (7/11/2025, 7:00:00 PM)
53.33
+0.33 (+0.62%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners64.65%
Inst Owner ChangeN/A
Ins Owners2.37%
Ins Owner ChangeN/A
Market Cap2.09B
Analysts50
Price Target56.92 (6.73%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.91% |
Yearly Dividend0.42
Dividend Growth(5Y)-34.89%
DP24.69%
Div Incr Years3
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.97%
Min EPS beat(2)-10.65%
Max EPS beat(2)-5.29%
EPS beat(4)0
Avg EPS beat(4)-5.72%
Min EPS beat(4)-10.65%
Max EPS beat(4)-0.99%
EPS beat(8)1
Avg EPS beat(8)-7.81%
EPS beat(12)4
Avg EPS beat(12)-2.16%
EPS beat(16)6
Avg EPS beat(16)12.76%
Revenue beat(2)0
Avg Revenue beat(2)-1.99%
Min Revenue beat(2)-2.12%
Max Revenue beat(2)-1.87%
Revenue beat(4)0
Avg Revenue beat(4)-2.27%
Min Revenue beat(4)-3.14%
Max Revenue beat(4)-1.87%
Revenue beat(8)1
Avg Revenue beat(8)-3.09%
Revenue beat(12)5
Avg Revenue beat(12)-0.11%
Revenue beat(16)8
Avg Revenue beat(16)0.85%
PT rev (1m)0%
PT rev (3m)13.68%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.73%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.73%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.67%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.33 | ||
| Fwd PE | 26.67 | ||
| P/S | 3.19 | ||
| P/FCF | 19.92 | ||
| P/OCF | 16.8 | ||
| P/B | 4.71 | ||
| P/tB | 18 | ||
| EV/EBITDA | 13.43 |
EPS(TTM)1.6
EY3%
EPS(NY)2
Fwd EY3.75%
FCF(TTM)2.68
FCFY5.02%
OCF(TTM)3.18
OCFY5.95%
SpS16.72
BVpS11.33
TBVpS2.96
PEG (NY)2.5
PEG (5Y)2.25
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.83% | ||
| ROE | 15.77% | ||
| ROCE | 16.31% | ||
| ROIC | 11.91% | ||
| ROICexc | 12.9% | ||
| ROICexgc | 33.53% | ||
| OM | 14.36% | ||
| PM (TTM) | 10.69% | ||
| GM | 33.63% | ||
| FCFM | 16.01% |
ROA(3y)9.88%
ROA(5y)11.71%
ROE(3y)15.44%
ROE(5y)22.37%
ROIC(3y)11.97%
ROIC(5y)12.76%
ROICexc(3y)12.48%
ROICexc(5y)13.78%
ROICexgc(3y)30.54%
ROICexgc(5y)29.2%
ROCE(3y)16.39%
ROCE(5y)17.47%
ROICexcg growth 3Y-1.36%
ROICexcg growth 5Y-1.14%
ROICexc growth 3Y4.48%
ROICexc growth 5Y-13.43%
OM growth 3Y-4.81%
OM growth 5Y-1.42%
PM growth 3Y-21.44%
PM growth 5Y-0.72%
GM growth 3Y-14.76%
GM growth 5Y-10.42%
F-Score5
Asset Turnover0.92
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 1.74 | ||
| Debt/EBITDA | 0.58 | ||
| Cap/Depr | 27.56% | ||
| Cap/Sales | 2.98% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 75.43% | ||
| Profit Quality | 149.79% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.22 | ||
| Altman-Z | 5.53 |
F-Score5
WACC7.57%
ROIC/WACC1.57
Cap/Depr(3y)36.55%
Cap/Depr(5y)30.34%
Cap/Sales(3y)3.8%
Cap/Sales(5y)3.06%
Profit Quality(3y)141.22%
Profit Quality(5y)125.45%
High Growth Momentum
Growth
EPS 1Y (TTM)5.26%
EPS 3Y-10.45%
EPS 5Y14.82%
EPS Q2Q%5.71%
EPS Next Y13.36%
EPS Next 2Y12.5%
EPS Next 3Y8.89%
EPS Next 5YN/A
Revenue 1Y (TTM)1.72%
Revenue growth 3Y13.91%
Revenue growth 5Y17.53%
Sales Q2Q%3.07%
Revenue Next Year3.95%
Revenue Next 2Y4.23%
Revenue Next 3Y3.67%
Revenue Next 5YN/A
EBIT growth 1Y0.8%
EBIT growth 3Y8.43%
EBIT growth 5Y15.86%
EBIT Next Year82.63%
EBIT Next 3Y25.61%
EBIT Next 5YN/A
FCF growth 1Y2.64%
FCF growth 3Y11.81%
FCF growth 5Y13.66%
OCF growth 1Y-5.87%
OCF growth 3Y13.94%
OCF growth 5Y15.32%